Formononetin Induces Apoptosis of Human Osteosarcoma Cell Line U2OS by Regulating the Expression of Bcl-2, Bax and MiR-375 In Vitro and In Vivo

被引:72
作者
Hu, Wei [1 ]
Xiao, ZengMing [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning 530021, Peoples R China
关键词
Formononetin; Bax; Bcl-2; U2OS; MiR-375; HUMAN BREAST-CANCER; SIGNALING PATHWAY; PROLIFERATION; INACTIVATION; CALYCOSIN; GENISTEIN;
D O I
10.1159/000430220
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Background/Aims: Phytoestrogens are known to prevent tumor progression by inhibiting proliferation and inducing apoptosis in cancer cells. Formononetin is one of the main components of red clover plants, and is considered as a typical phytoestrogen. This study investigates formononetin induction of apoptosis of human osteosarcoma cell line U2OS by regulating Bcl-2 and Bax expression in vitro and in vivo. Methods: U2OS cells were treated with different concentrations of formononetin and the proliferation of the cells was measured using an MTT assay. Cell apoptosis was examined by flow cytometry. The levels of miR-375, Bax and Bcl-2 protein expression in treated cells were determined by Western blot and RT-PCR. The antitumor activity of formononetin was also evaluated in vivo in nude mice bearing orthotopic tumor implants. Results: High concentrations of formononetin significantly suppress the proliferation of U2OS cells and induce cell apoptosis. Moreover, compared to control group the expression of Bcl-2 and miR-375 decreases with formononetin in the U2OS cells, while Bax increases. Conclusion: Formononetin has inhibitory effects on the proliferation of U2SO cells, both in vitro and in vivo. This antitumor effect is directly correlated with formononetin concentration.(C) 2015 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:933 / 939
页数:7
相关论文
共 20 条
[1]
Soy processing influences growth of estrogen-dependent breast cancer tumors [J].
Allred, CD ;
Allred, KF ;
Ju, YH ;
Goeppinger, TS ;
Doerge, DR ;
Helferich, WG .
CARCINOGENESIS, 2004, 25 (09) :1649-1657
[2]
Calycosin Suppresses Breast Cancer Cell Growth via ERβ-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways [J].
Chen, Jian ;
Hou, Ruanling ;
Zhang, Xing ;
Ye, Yu ;
Wang, Yong ;
Tian, Jing .
PLOS ONE, 2014, 9 (03)
[3]
Estrogen Receptor Beta-Mediated Proliferative Inhibition and Apoptosis in Human Breast Cancer by Calycosin and Formononetin [J].
Chen, Jian ;
Zhao, Xinge ;
Ye, Yu ;
Wang, Yong ;
Tian, Jing .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (06) :1790-1797
[4]
Chen J, 2015, FOOD FUNCT, V6, P995, DOI [10.1039/C4FO01141D, 10.1039/c4fo01141d]
[5]
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer [J].
Davids, Matthew S. ;
Letai, Anthony .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3127-3135
[6]
MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 [J].
Ding, Ling ;
Xu, Yanjun ;
Zhang, Wei ;
Deng, Yujie ;
Si, Misi ;
Du, Ying ;
Yao, Haomi ;
Liu, Xuyan ;
Ke, Yuehai ;
Si, Jianmin ;
Zhou, Tianhua .
CELL RESEARCH, 2010, 20 (07) :784-793
[7]
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska natives [J].
Espey, David K. ;
Wu, Xiao-Cheng ;
Swan, Judith ;
Wiggins, Charles ;
Jim, Melissa A. ;
Ward, Elizabeth ;
Wingo, Phyllis A. ;
Howe, Holly L. ;
Ries, Lynn A. G. ;
Miller, Barry A. ;
Jemal, Ahmedin ;
Ahmed, Faruque ;
Cobb, Nathaniel ;
Kaur, Judith S. ;
Edwards, Brenda K. .
CANCER, 2007, 110 (10) :2119-2152
[8]
Hsieh CY, 1998, CANCER RES, V58, P3833
[9]
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies [J].
Lamoureux, Frangois ;
Trichet, Valerie ;
Chipoy, Celine ;
Blanchard, Frederic ;
Gouin, Francois ;
Redini, Francoise .
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (02) :169-181
[10]
Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway [J].
Lee, Chia-Hsin ;
Huang, Yu-Ling ;
Liao, Jyh-Fei ;
Chiou, Wen-Fei .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 676 (1-3) :26-33